These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16018865)

  • 1. Regression analysis of percutaneous coronary intervention treatment-related time delay.
    MacDonald RD; Welsford M; Arntz HR
    Am J Cardiol; 2005 Jul; 96(2):322. PubMed ID: 16018865
    [No Abstract]   [Full Text] [Related]  

  • 2. The year in interventional cardiology.
    Dixon SR; Grines CL; O'Neill WW
    J Am Coll Cardiol; 2007 Jul; 50(3):270-85. PubMed ID: 17631221
    [No Abstract]   [Full Text] [Related]  

  • 3. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.
    Tarantini G; Razzolini R; Napodano M; Bilato C; Ramondo A; Iliceto S
    Eur Heart J; 2010 Mar; 31(6):676-83. PubMed ID: 19946106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary angiography and percutaneous coronary intervention after fibrinolytic therapy: when and for whom?
    Sharma S
    Indian Heart J; 2009; 61(5):443-7. PubMed ID: 20635759
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolytic therapy for acute ST-segment elevation myocardial infarction: should it be given to all patients prior to urgent PCI?
    Conti CR
    Clin Cardiol; 2006 Mar; 29(3):93-5. PubMed ID: 16596829
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention.
    Schofield PM
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii7-11. PubMed ID: 15919654
    [No Abstract]   [Full Text] [Related]  

  • 7. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration.
    de Boer SP; Barnes EH; Westerhout CM; Simes RJ; Granger CB; Kastrati A; Widimsky P; de Boer MJ; Zijlstra F; Boersma E
    Am Heart J; 2011 Mar; 161(3):500-507.e1. PubMed ID: 21392604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
    Borgia F; Goodman SG; Halvorsen S; Cantor WJ; Piscione F; Le May MR; Fernández-Avilés F; Sánchez PL; Dimopoulos K; Scheller B; Armstrong PW; Di Mario C
    Eur Heart J; 2010 Sep; 31(17):2156-69. PubMed ID: 20601393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis.
    Betriu A; Masotti M
    Am J Cardiol; 2005 Jan; 95(1):100-1. PubMed ID: 15619401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction.
    Tarantini G; Razzolini R; Ramondo A; Napodano M; Bilato C; Iliceto S
    Am J Cardiol; 2005 Dec; 96(11):1503-5. PubMed ID: 16310430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombus aspiration during percutaneous coronary intervention.
    Bonello L; De Labriolle A; Steinberg D; Waksman R
    Lancet; 2008 Sep; 372(9643):1034; author reply 1034-5. PubMed ID: 18805323
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
    Singh S; Gopal AK; Bahl VK
    Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study).
    Le May MR; Wells GA; Labinaz M; Davies RF; Turek M; Leddy D; Maloney J; McKibbin T; Quinn B; Beanlands RS; Glover C; Marquis JF; O'Brien ER; Williams WL; Higginson LA
    J Am Coll Cardiol; 2005 Aug; 46(3):417-24. PubMed ID: 16053952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal reperfusion strategy for acute myocardial infarction.
    Dzielicka E; Swanton H
    Br J Hosp Med (Lond); 2008 Jan; 69(1):18-23. PubMed ID: 18293723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Zwolle global experience on primary percutaneous coronary intervention.
    De Luca G; Suryapranata H; de Boer MJ
    Ital Heart J; 2005 Jun; 6(6):453-8. PubMed ID: 16008149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing reperfusion in patients with STEMI: a critical evaluation of pharmacologic and non-pharmacologic strategies.
    Yang X; Pinto DS; Chakrabarti AK
    Am J Cardiovasc Drugs; 2013 Dec; 13(6):399-406. PubMed ID: 24043331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion damage or no-reflow damage in primary coronary interventions in acute myocardial infarction?
    Widimský P
    Eur Heart J; 2002 Jul; 23(14):1076-8. PubMed ID: 12090742
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of fibrinolysis in the era of primary percutaneous coronary intervention.
    Halvorsen S; Huber K
    Thromb Haemost; 2011 Mar; 105(3):390-5. PubMed ID: 21136014
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of acute coronary syndromes.
    Parchure N; Brecker SJ
    Curr Opin Crit Care; 2002 Jun; 8(3):230-5. PubMed ID: 12386502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing the benefits of primary angioplasty against the benefits of thrombolytic therapy for acute myocardial infarction: the importance of timing.
    Kent DM; Lau J; Selker HP
    Eff Clin Pract; 2001; 4(5):214-20. PubMed ID: 11685979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.